The highest dose of an experimental drug developed by Eli Lilly significantly reduced levels of a genetically inherited risk ...

The drug's effects lasted six months with no major side effects, according to new research presented in Chicago Sunday at an American College of Cardiology meeting and also published in the New ...

New drug shows success lowering genetically inherited heart disease risk Nearly a quarter of the world's population has elevated risk, doctor says Elevated lipoprotein levels bring the risk of ...

While the drug reduced a cardiovascular risk factor, large trials are needed to prove that lowering Lp(a) actually cuts heart attacks and other adverse cardiovascular events, Nissen said.